Using motivational interviewing to improve outcomes in COPD patients
Effect of Motivational Interviewing Based on Pender's Health Promotion Model on Patient-Reported Outcomes in Patients With COPD
This study is trying to see if motivational interviewing by nurses can help improve the quality of life for people with COPD who have been in treatment for at least six months.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ataturk University Academic / other |
| Locations | 1 site (Erzurum) |
| Trial ID | NCT06783582 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of motivational interviewing based on Pender's health promotion model in enhancing patient-reported outcomes for individuals with Chronic Obstructive Pulmonary Disease (COPD). The intervention focuses on the role of nurses in providing holistic care and support to patients, addressing both physical and psychological challenges associated with COPD. Participants will engage in online interviews to assess the impact of this approach on their quality of life and overall health management. The study targets patients who have been receiving treatment for COPD for at least six months and are in GOLD Stage II or III of the disease.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old with GOLD Stage II or III COPD who have been receiving treatment for more than six months.
Not a fit: Patients with GOLD Stage I or IV COPD, those experiencing exacerbations, or individuals with serious comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and health outcomes for patients with COPD.
How similar studies have performed: Previous studies have shown promising results using motivational interviewing in chronic disease management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being over 18 years of age, * Volunteering to participate in the study, * Being literate, * Having GOLD Stage II and III COPD, * Receiving COPD treatment for more than 6 months, * Having a smartphone for online interviews, * Not having sensory loss related to hearing and vision, * Not having a history of psychiatric diagnosis, * Being suitable for applying cognitive level scales. Exclusion Criteria: * Having GOLD Stage I and IV COPD, * Having serious pulmonary and malignant disease, * Not being able to communicate in Turkish, * Being in an exacerbation period, * Having a history of psychiatric diagnosis.
Where this trial is running
Erzurum
- Ataturk University — Erzurum, Turkey (Türkiye) (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.